During the past decade, Vedanta Institute of Medical Sciences conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vedanta Institute of Medical Sciences" #1 collaborator was "Cephalon" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Vedanta Institute of Medical Sciences" are "Advanced Non-small Cell Lung Cancer (NSCLC)" (1 trials), "Chronic Hepatitis B" (1 trials), "Extensive-stage Small Cell Lung Cancer" (1 trials), "Non-Small Cell Lung Cancer" (1 trials) and "Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Vedanta Institute of Medical Sciences" in a lesser frequency.

Most popular intervention types in "Vedanta Institute of Medical Sciences" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Active Comparator (erlotinib)" (1 trials), "Bevacizumab" (1 trials), "CS-7017" (1 trials), "Carboplatin/etoposide" (1 trials) and "Dacomitinib (PF-00299804)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vedanta Institute of Medical Sciences" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Vedanta Institute of Medical Sciences". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Vedanta Institute of Medical Sciences, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Vedanta Institute of Medical Sciences, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".